Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis.

King, Susannah J; Keating, Dominic; Williams, Elyssa; Paul, Eldho; Borg, Brigitte M; Finlayson, Felicity; Button, Brenda M; Wilson, John W; Kotsimbos, Tom

King, Susannah J; Keating, Dominic; Williams, Elyssa; Paul, Eldho; Borg, Brigitte M; Finlayson, Felicity; Button, Brenda M; Wilson, John W; Kotsimbos, Tom.

Afiliación

King SJ; Nutrition Dept, Alfred Hospital, Melbourne, Australia.
Keating D; Cystic Fibrosis Service, Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia.
Williams E; Dept of Dietetics, Nutrition and Sport, LaTrobe University, Bundoora, Australia.
Paul E; Cystic Fibrosis Service, Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia.
Borg BM; Dept of Medicine, Monash University, Melbourne, Australia.
Finlayson F; Cystic Fibrosis Service, Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia.
Button BM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Wilson JW; Physiology Service, Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia.
Kotsimbos T; Cystic Fibrosis Service, Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia.

ERJ Open Res ; 7(1)2021 Jan.

Article en En | MEDLINE | ID: mdl-33569502

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: ERJ Open Res Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google